They also showed that CRISPR–Cas9 mediated knockout of PRKAA2 in NF1-mutant melanoma cells promoted anchorage-independent growth in soft agar, while ectopic expression of PRKAA2 in NF1- and AMPK-α2-deficient human melanoma cells greatly reduced anchorage-independent growth. This evidence concerns the gene NF1 and melanoma.